Nemdx Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Nemdx General Information
Description
Developer of a medical diagnostic platform designed to analyze protein function in neurodegenerative diseases. The company's platform quantifies the change in the functional activity of the protein and shows data on alternative splicing, post-translational modifications, and conformation changes of proteins in patients, enabling the pharmaceutical industry to diagnose neurodegenerative diseases earlier.
Contact Information
Website
www.nemdx.comCorporate Office
- 2000 Commonwealth Avenue
- Suite 200
- Auburndale, MA 02466
- United States
Corporate Office
- 2000 Commonwealth Avenue
- Suite 200
- Auburndale, MA 02466
- United States
Nemdx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jan-2022 | Completed | Generating Revenue |
Nemdx Signals
Nemdx Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 20/20 HealthCare Partners | Family Office | Minority |
Nemdx FAQs
-
When was Nemdx founded?
Nemdx was founded in 2021.
-
Where is Nemdx headquartered?
Nemdx is headquartered in Auburndale, MA.
-
What is the size of Nemdx?
Nemdx has 7 total employees.
-
What industry is Nemdx in?
Nemdx’s primary industry is Discovery Tools (Healthcare).
-
Is Nemdx a private or public company?
Nemdx is a Private company.
-
What is Nemdx’s current revenue?
The current revenue for Nemdx is .
-
Who are Nemdx’s investors?
20/20 HealthCare Partners has invested in Nemdx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process